olm26250 / iStockphoto.com
The US Court of Appeals for the Federal Circuit has overturned a reduction in the patent term adjustment (PTA) owned by Supernus Pharmaceuticals.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Supernus Pharmaceuticals, US Court of Appeals for the Federal Circuit, patent term adjustment, Sandoz, patent litigation, pharmaceuticals